Illuminare Biotechnologies

New York, NY · Founded 2016 · Privately Held (backing)

Developer of an intra-operative nerve visualization technology intended to reduce the risk of nerve damage. Illuminare Biotechnologies is based in New York, NY and was founded in 2016. Its last reported valuation was $11.4 million in Aug 2017. It has raised $7.1 million across 1 recorded round; the latest was a $3.6 million seed round in May 2026.

Last reported valuation
$11.4M
Oct 2026
Priced at
—
Total raised
$7.1M
Last round
Seed Round
May 2026
How much has Illuminare Biotechnologies raised?
$7.1Macross 1 recorded rounds · May 2026 – May 2026

Most recently, Illuminare Biotechnologies raised $3.6M in its Seed Round (May 2026).

Free account
More of Illuminare Biotechnologies with a free account
  • ·Watch Illuminare Biotechnologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Illuminare Biotechnologies round by round

1 rounds
May 2026Seed Round$3.6MSEC filing▮
42 investors participated

How much has Illuminare Biotechnologies raised?

Illuminare Biotechnologies has raised $7.1 million in total; 1 of its rounds is on record. The largest on record was a $3.6 million seed round in May 2026.

Illuminare Biotechnologies has filed 1 Form D with the SEC, most recently in Dec 2018 (null sold).

Illuminare Biotechnologies investors

4 investors are on record for Illuminare Biotechnologies, including Memorial Sloan Kettering Cancer Center, Endo Investors, GE Aerospace and Thylacine Capital. The seed round in May 2026 drew 42 investors.

For fundraisers
Raising for a company like Illuminare Biotechnologies?

4 investors have backed Illuminare Biotechnologies.

See all 4 investors →

Frequently asked about Illuminare Biotechnologies

How much has Illuminare Biotechnologies raised?
Illuminare Biotechnologies has raised $7.1M in total across 1 recorded funding rounds.
When was Illuminare Biotechnologies's last funding round?
Illuminare Biotechnologies's most recent recorded round was Seed Round in May 2026, raising $3.6M.